Unveiling novel CSF protein biomarkers in primary CNS lymphoma: A pilot study

Key Points

• Identifying new csf biomarkers may improve diagnosis for primary cns lymphoma, enhancing patient outcomes.
• The study highlights potential protein markers that could distinguish primary cns lymphoma from other conditions.
• Observational analysis of csf proteins was conducted in patients diagnosed with primary cns lymphoma, providing insight into their profiles.
• These findings support the need for further validation of biomarkers in larger, diverse populations.